Jaundiced Eyes - Causes, Treatment & When to See a Doctor

```html

What is Jaundiced Eyes?

“Jaundiced eyes,” also called icteric sclerae or “yellow eyes,” refer to a yellow‑tinted appearance of the whites (sclera) of the eyes. The underlying pigment is bilirubin, a yellow‑orange by‑product of the normal breakdown of red blood cells. When bilirubin levels in the bloodstream rise faster than the liver can process and eliminate it, the excess diffuses into tissues—including the sclera—causing the characteristic yellow hue.

Jaundice is most often thought of as a skin symptom, but the sclera is actually the first place many people notice the color change because it is highly vascular and more sensitive to small increases in bilirubin (as low as 2–3 mg/dL). Recognizing jaundiced eyes early can prompt evaluation for potentially serious liver, blood, or biliary disorders.

Common Causes

Jaundice results from an imbalance in bilirubin production, processing, or excretion. Below are the most frequent conditions that can produce yellow eyes:

• Hepatitis (viral, alcoholic, drug‑induced) – inflammation impairs the liver’s ability to conjugate bilirubin.
• Gallstones (choledocholithiasis) – blockage of the bile ducts prevents bilirubin from leaving the liver.
• Alcoholic liver disease & cirrhosophic scarring – chronic injury reduces functional liver mass.
• Non‑alcoholic fatty liver disease (NAFLD) / steatohepatitis – metabolic fat buildup leads to inflammation and reduced bilirubin clearance.
• Hemolytic anemia – rapid destruction of red blood cells overwhelms the liver’s capacity to process bilirubin.
• Gilbert’s syndrome – a common, benign genetic reduction in the enzyme UDP‑glucuronosyltransferase, causing intermittent mild jaundice.
• Biliary tract cancer or pancreatic head tumor – physically obstructs bile flow.
• Sepsis or severe infections – can cause liver dysfunction and cholestasis.
• Medication‑induced cholestasis – drugs such as certain antibiotics (e.g., amoxicillin‑clavulanate), anabolic steroids, and some chemotherapy agents.
• Neonatal physiologic jaundice – newborns often have immature liver enzymes; the sclera may turn yellow within the first few days of life.

Associated Symptoms

The presence of yellow eyes rarely occurs in isolation. Look for these accompanying signs that can help narrow the underlying cause:

• Dark‑brown or “tea‑colored” urine
• Pale, chalky stools (suggesting obstructive jaundice)
• Abdominal pain, especially in the right upper quadrant
• Fatigue, weakness, or unexplained weight loss
• Pruritus (itchy skin) – common when bile salts accumulate under the skin
• Fever or chills (possible infection or cholangitis)
• Abdominal swelling (ascites) or spider‑like blood vessels on the skin (spider angiomas)
• Bruising or easy bleeding (impaired clotting factor production)
• Joint pain or dark urine in hemolytic anemia
• In newborns: poor feeding, lethargy, or a high‑pitch cry

When to See a Doctor

Because jaundice can signal a spectrum from benign to life‑threatening disease, timely medical evaluation is essential. Seek care promptly if you notice any of the following:

• Yellowing of the eyes or skin that persists more than 24–48 hours.
• Accompanying dark urine, pale stools, or severe itching.
• Persistent abdominal pain, especially in the upper right quadrant.
• Fever, chills, or worsening malaise.
• Unexplained weight loss, loss of appetite, or vomiting.
• Bleeding gums, easy bruising, or a sudden change in mental status (confusion, drowsiness).
• In infants: yellow eyes with poor feeding, lethargy, or a swelling abdomen.

Even mild, intermittent jaundice (as seen in Gilbert’s syndrome) should be discussed with a clinician to rule out other causes.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted laboratory and imaging studies.

1. History & Physical Examination

• Recent medication or supplement use, alcohol intake, and travel history.
• Family history of liver disease or hemolytic disorders.
• Examination of the sclera, skin, abdomen (hepatomegaly, tenderness), and any signs of chronic liver disease.

2. Blood Tests

• Serum bilirubin – total, direct (conjugated) and indirect (unconjugated) fractions.
• Liver function panel – AST, ALT, alkaline phosphatase (ALP), gamma‑glutamyl transpeptidase (GGT), albumin.
• Complete blood count (CBC) – to detect hemolysis or infection.
• Coagulation profile (PT/INR) – assesses synthetic liver function.
• Viral hepatitis serologies (HBV, HCV), autoimmune markers (ANA, SMA), iron studies (ferritin, transferrin saturation), and alpha‑1 antitrypsin levels when indicated.

3. Imaging Studies

• Abdominal ultrasound – first‑line for detecting gallstones, biliary duct dilation, or liver lesions.
• CT or MRI – provides detailed anatomy, especially for tumors or complex biliary pathology.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive visualization of the biliary tree.
• In selected cases, an endoscopic retrograde cholangiopancreatography (ERCP) may be therapeutic as well as diagnostic.

4. Specialized Tests

• Liver biopsy – reserved for unclear cases when chronic hepatitis, NAFLD, or autoimmune disease is suspected.
• Hemolysis work‑up – haptoglobin, lactate dehydrogenase (LDH), reticulocyte count, peripheral smear.

Treatment Options

Treatment is directed at the underlying cause; the yellow discoloration itself usually resolves once bilirubin levels normalize.

Medical Management

• Viral hepatitis – antiviral agents (e.g., tenofovir for HBV, direct‑acting antivirals for HCV).
• Obstructive cholestasis – endoscopic stone extraction, stenting, or surgery to relieve biliary blockage.
• Alcoholic liver disease – abstinence, nutritional support, corticosteroids in severe alcoholic hepatitis.
• NAFLD/NASH – weight loss (7–10 % of body weight), control of diabetes/hyperlipidemia, vitamin E in select patients.
• Hemolytic anemia – treat underlying trigger (e.g., stop offending drug), corticosteroids for autoimmune hemolysis, or exchange transfusion in severe cases.
• Gilbert’s syndrome – usually no treatment needed; educate the patient about triggers (fasting, stress, certain meds).
• Medication‑induced cholestasis – discontinue the offending drug; consider ursodeoxycholic acid for symptomatic relief.
• Infections/Sepsis – appropriate antibiotics, source control, and supportive care.

Supportive & Home Care

• Stay well‑hydrated to aid bilirubin excretion.
• Maintain a balanced diet rich in fruits, vegetables, and lean protein; limit fried and high‑fat foods.
• Avoid alcohol and hepatotoxic substances.
• If itching is severe, topical menthol or oral antihistamines can provide relief; cholestyramine is an option for cholestatic pruritus.
• Rest and avoid strenuous activity until the underlying cause is clarified.

Prevention Tips

While some causes (genetic conditions) cannot be prevented, many risk factors are modifiable:

• Limit alcohol consumption to ≤ 1 drink/day for women and ≤ 2 drinks/day for men.
• Vaccinate against hepatitis A and B if you are at risk.
• Practice safe sex and avoid sharing needles to reduce viral hepatitis transmission.
• Maintain a healthy weight (BMI < 25) to lower NAFLD risk.
• Adopt a Mediterranean‑style diet rich in omega‑3 fatty acids, whole grains, and antioxidants.
• Use medications only as prescribed; discuss any over‑the‑counter or herbal supplements with your doctor.
• Seek prompt medical attention for unexplained jaundice in newborns—early phototherapy can prevent kernicterus.

Emergency Warning Signs

Key Take‑aways

Jaundiced eyes are a visible sign that bilirubin is building up in the body. While sometimes harmless (e.g., Gilbert’s syndrome), they often point to liver, biliary, or blood‑cell problems that need evaluation. Early detection, thorough diagnostic work‑up, and targeted treatment can prevent complications and restore normal eye coloration.

Always discuss new or worsening yellowing with a health‑care professional, especially if accompanied by pain, fever, itching, or changes in urine/stool color.

---

References:

• Mayo Clinic. “Jaundice.” Mayoclinic.org, 2023.
• American Liver Foundation. “Understanding Jaundice.” liverfoundation.org, 2022.
• Cleveland Clinic. “Biliary Obstruction.” clevelandclinic.org, 2023.
• World Health Organization. “Hepatitis B Fact Sheet.” who.int, 2024.
• National Institute of Diabetes and Digestive and Kidney Diseases. “Non‑Alcoholic Fatty Liver Disease.” niddk.nih.gov, 2023.

```